BOTOX® Treatment in Pediatric Upper Limb Spasticity

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 235 participants.

Also called NCT01603602

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 235 participants (enrolled count) (from the registry)
Sponsor
Allergan (from the registry)
Registry
  • NCT NCT01603602
  • EudraCT 2012-000062-38
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, Hungary, Philippines, Poland, Russia, South Korea, Thailand, Türkiye (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01603602. Randomized; quadruple masking; primary purpose treatment. Start 2012-07-12 (actual); primary completion 2017-06-29 (actual). Results posted on 2018-08-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BOTOX® Treatment in Pediatric Upper Limb Spasticity
Condition
Pediatrics
Condition
Muscle Spasticity
Condition
Cerebral Palsy
Condition
Stroke
Intervention (Biological)
botulinum toxin Type A
Intervention (Drug)
Normal Saline (Placebo)
Lead sponsor
Allergan (class: industry)

Record details

Record id
cardio:ct-nct01603602
Content hash
024ca9536a1b74e5e28f46297f016852d076d472c868a9ab828a6619916bafb5